PTH and chronic kidney disease: The secondary hyperparathyroidism (SHPT) in chronic kidney disease (CKD), characterized by elevated parathyroid hormone (PTH), parathyroid gland overgrowth, and disordered mineral metabolism, is a major contributor to the high rates of bone disease and cardiovascular mortality in CKD patients [3].